Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Three cost-effective methods accurately measure finasteride in pharmaceuticals, better than current techniques.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

A man developed an allergic skin reaction after using brimonidine for rosacea.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

BMS-470539 reduces skin fibrosis and inflammation.